Fig 1:
![Fig 1:. Time to death in subjects who underwent HSCT (median time: 12 [3.0 – 17.0] months) was significantly longer than in subjects who did not undergo HSCT (median time: 27 [16.0 –NA] months). p-value: 0.02 (log-rank test).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/116/21/10.1182_blood.v116.21.2155.2155/3/bld0011000300004.jpeg?Expires=1754658095&Signature=RxVI1xjiHsAaYrbyeTqcrd4P~Aw2D0vC4PTo39z~aG95mhc3-vYPQl6d7RdaAUviqVJOWLn91dRkxxt55j7i-CwF2IylflB5iVvtHzjs4c210TM5CW5LZDWGcuwHqjKEpd2x1srVaWEzEXM~DpSNZpzvsisTDiyjfGBRF9MJa1qFsF-cjdvcOs1PnLn6Xpn0gqU7g~f8jV2paVXgAu44aFQg3ZJPRX2SQvTKNac6jZslsA~ck-FOeJZLxYvg7qh0NRlxCRYi7dARUzhZwwJtbvlbsLeToune1JQAEYIcP~CDgpyl31ZhXR86JlUU~jOyC3YmG8B06du0cRxOucot6w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time to death in subjects who underwent HSCT (median time: 12 [3.0 – 17.0] months) was significantly longer than in subjects who did not undergo HSCT (median time: 27 [16.0 –NA] months). p-value: 0.02 (log-rank test).
Time to death in subjects who underwent HSCT (median time: 12 [3.0 – 17.0] months) was significantly longer than in subjects who did not undergo HSCT (median time: 27 [16.0 –NA] months). p-value: 0.02 (log-rank test).
